William L. Mentlik

Aaron S. Eckenthal

ANDA filing sparks Celgene clash over generic REVLIMID®, challenging 16 patents on `polymorphic forms` and computer-implemented drug safety systems.

Name	Ratings
Quinn Emanuel Urquhart & Sullivan LLP	L5 A
F. Dominic Cerrito	L5 A
Eric C. Stops	L4 C
Andrew S. Chalson	L2 B
Frank C. Calvosa	L2 B
Brian J. Forsatz	L2 C
Marta Godecki	L1 C
Jones Day	L5 A
Steven J. Corr	L3 B
Evangeline Shih	L3 B
J. Patrick Elsevier	L3 B
Matthew J. Hertko	L3 C
Gabriel P. Brier	L2 C
Cary Miller	L1 C
Saul Ewing LLP	L3 B
William C. Baton	L5 A
Charles M. Lizza	L5 A
Sarah Ann Sullivan	L5 A
David L. Moses	L2 B

Name	Ratings
Lotus Pharmaceutical Co Ltd	-- -- --
Alvogen Pine Brook LLC	L1 C

Name	Ratings
Lerner David Littenberg Krumholz & Mentlik LLP	L3 E
William L. Mentlik	L5 E
Tedd W. van Buskirk	L2 E
Aaron S. Eckenthal	L1 E